Solventum's Cash & cash equivalent grew by 11.91 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Solventum's Quick Ratio to 0.13, Quick Ratio remained below Solventum Corporation average.

Within Medical Equipment & Supplies industry 184 other companies have achieved higher Quick Ratio than Solventum in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 2911 to 3736.

Explain Quick Ratio?
How much Cash & cash equivalents SOLV�s has?
What are SOLV�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SOLV/financial-strength

https://api.csimarket.com/api/v1/companies/SOLV/fundamentals

https://api.csimarket.com/api/v1/companies/SOLV/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

SOLV Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	132.44 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-72.53 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.13	Subscribe	Subscribe	Subscribe	Subscribe
SOLV's Total Ranking	# 3736	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-2.4 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	11.91 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 185
Healthcare Sector	# 850
Overall Market	# 3736

Quick Ratio Statistics
High	Average	Low
1.35	0.54	0.11
(Mar 31 2024)		(Jun 30 2026)

Financial Statements
Solventum's Current Liabilities	$ 3,575 Millions	Visit SOLV's Balance sheet
Solventum's Cash & cash equivalent	$ 451 Millions	Visit SOLV's Balance sheet
Source of SOLV's Sales		Visit SOLV's Sales by Geography

Cumulative Solventum's Quick Ratio

SOLV's Quick Ratio for the trailling 12 Months

SOLV Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	118.43 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-19.88 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.21	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4083	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	23.35 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-34.18 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to SOLV Financial Strength Comparisons >> Go to Compare SOLV Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $3,575.00 millions, cumulative Quick Ratio decreased to 0.21 below the Solventum Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Solventum. While Quick Ratio overall ranking has improved so far to 4083, from total ranking during the twelve months ending second quarter 2026 at 4092.

Explain Quick Ratio?
How much Cash & cash equivalents SOLV�s has?
What are SOLV�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 206
Healthcare Sector	# 908
Within the Market	# 4083

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.32	0.28	0.2
(Dec 31 2024)		(Jun 30 2025)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Tela Bio Inc	0.31	$ 22.664 Millions	$ 73.706 Millions
Tandem Diabetes Care Inc	0.28	$ 72.840 Millions	$ 256.075 Millions
Ufp Technologies Inc	0.27	$ 20.625 Millions	$ 77.359 Millions
Docgo Inc	0.26	$ 20.569 Millions	$ 79.655 Millions
Bausch and Lomb Corp	0.25	$ 513.000 Millions	$ 2,019.000 Millions
Accuray Incorporated	0.25	$ 42.254 Millions	$ 170.106 Millions
Cerus Corporation	0.20	$ 16.350 Millions	$ 80.006 Millions
Bioventus Inc	0.19	$ 30.709 Millions	$ 159.282 Millions
Dentsply Sirona Inc	0.15	$ 195.000 Millions	$ 1,312.000 Millions
Boston Scientific Corporation	0.13	$ 904.000 Millions	$ 7,150.000 Millions
Solventum Corporation	0.13	$ 451.000 Millions	$ 3,575.000 Millions
The Pennant Group Inc	0.12	$ 18.389 Millions	$ 151.730 Millions
Zimmer Biomet Holdings Inc	0.11	$ 399.900 Millions	$ 3,502.400 Millions
Integer Holdings Corporation	0.07	$ 14.135 Millions	$ 201.125 Millions
3m Company	0.03	$ 322.000 Millions	$ 11,868.000 Millions

Date modified: 2026-11-08T13:46:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.